Capital World Investors

Capital World Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Capital World Investors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,443,000	Closed	-$35.9M	–	560
2019 Q4	$35.9M	Hold	3,443,000	–	–	0.01%	374
2019 Q3	$13.5M	Buy	3,443,000 +1,682,963	+96%	+$13.6M	﹤0.01%	448
2019 Q2	$26.2M	Buy	1,760,037 +1,227,037	+230%	+$22.2M	0.01%	408
2019 Q1	$13.2M	Hold	533,000	–	–	﹤0.01%	465
2018 Q4	$9.57M	Hold	533,000	–	–	﹤0.01%	474
2018 Q3	$15.7M	Sell	533,000 -119,000	-18%	-$4.61M	﹤0.01%	486
2018 Q2	$29.6M	Hold	652,000	–	–	0.01%	422
2018 Q1	$34.4M	Buy	+652,000	New	+$38M	0.01%	383

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return